MedPath

ALEXANDRIA UNIVERSITY

ALEXANDRIA UNIVERSITY logo
🇪🇬Egypt
Ownership
Private
Established
1942-01-01
Employees
1.5K
Market Cap
-
Website
http://www.alexu.edu.eg

Clinical Trials

474

Active:15
Completed:286

Trial Phases

6 Phases

Early Phase 1:5
Phase 1:11
Phase 2:44
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (417 trials with phase data)• Click on a phase to view related trials

Not Applicable
298 (71.5%)
Phase 2
44 (10.6%)
Phase 4
36 (8.6%)
Phase 3
23 (5.5%)
Phase 1
11 (2.6%)
Early Phase 1
5 (1.2%)

ESPB Versus Perioperative Iv Lidocaine Infusion on Proinflammatory Cytokines in Breast Cancer Surgeries

Not Applicable
Not yet recruiting
Conditions
Breast Cancer
ESPB
Lidocaine Infusion
First Posted Date
2025-08-07
Last Posted Date
2025-08-07
Lead Sponsor
Alexandria University
Target Recruit Count
40
Registration Number
NCT07108959
Locations
🇪🇬

Faculty of Medicine , Alexandria University, Alexandria, Egypt

Transcranial Doppler in Traumatic Brain Edema

Completed
Conditions
Traumatic Brain Injury
First Posted Date
2025-08-06
Last Posted Date
2025-08-12
Lead Sponsor
Alexandria University
Target Recruit Count
70
Registration Number
NCT07107997
Locations
🇪🇬

Alexandria Main University Hospital, Alexandria, Other (Specify), Egypt

Sagittal Split Plate Versus Two Miniplates in the Treatment of Mandibular Angle Fractures

Not Applicable
Recruiting
Conditions
Mandible Fracture
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
Alexandria University
Target Recruit Count
16
Registration Number
NCT07103590
Locations
🇪🇬

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt

EFFECT OF LACTASE ENZYME SUPPLEMENT ON PROTECTION AGAINST FEEDING INTOLERENCE IN PRETERM NEONATES

Not Applicable
Not yet recruiting
Conditions
Premature
Feeding Disorders
Lactase Deficiency, Congenital
Interventions
Drug: lactase administration
Other: placebo
First Posted Date
2025-07-28
Last Posted Date
2025-07-28
Lead Sponsor
Alexandria University
Target Recruit Count
120
Registration Number
NCT07088302

Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Hypoxic-Ischemic Encephalopathy
Neonatal Encephalopathy
Pentoxifylline Adverse Reaction
Interventions
Other: placebo distilled water
First Posted Date
2025-07-28
Last Posted Date
2025-07-28
Lead Sponsor
Alexandria University
Target Recruit Count
30
Registration Number
NCT07088328
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 91
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.